Division of Cardiology, Pulmonology, and Vascular Medicine, Medical Faculty, Heinrich-Heine-University, University Hospital Düsseldorf, Düsseldorf, Germany.
Division of Cardiology, Pulmonology, and Vascular Medicine, Medical Faculty, Heinrich-Heine-University, University Hospital Düsseldorf, Düsseldorf, Germany.
JACC Cardiovasc Imaging. 2022 Mar;15(3):519-532. doi: 10.1016/j.jcmg.2021.08.017. Epub 2021 Oct 13.
Applications of virtual reality (VR) and augmented reality (AR) assist both health care providers and patients in cardiovascular education, complementing traditional learning methods. Interventionalists have successfully used VR to plan difficult procedures and AR to facilitate complex interventions. VR/AR has already been used to treat patients, during interventions in rehabilitation programs and in immobilized intensive care patients. There are numerous additional potential applications in the catheterization laboratory. By using AR, interventionalists could combine visual fluoroscopy information projected and registered on the patient body with data derived from preprocedural imaging and live fusion of different imaging modalities such as fluoroscopy with echocardiography. Persistent technical challenges to overcome include the integration of different imaging modalities into VR/AR and the harmonization of data flow and interfaces. Cybersickness might exclude some patients and users from the potential benefits of VR/AR. Critical ethical considerations arise in the application of VR/AR in vulnerable patients. In addition, digital applications must not distract physicians from the patient. It is our duty as physicians to participate in the development of these innovations to ensure a virtual health reality benefit for our patients in a real-world setting. The purpose of this review is to summarize the current and future role of VR and AR in different fields within cardiology, its challenges, and perspectives.
虚拟现实 (VR) 和增强现实 (AR) 的应用有助于医疗保健提供者和患者进行心血管教育,补充了传统的学习方法。介入医生已经成功地使用 VR 来规划困难的手术,使用 AR 来协助复杂的介入手术。VR/AR 已经被用于治疗患者,在康复计划中的介入治疗以及在固定的重症监护患者中。在导管室中还有许多其他潜在的应用。通过使用 AR,介入医生可以将透视信息与从术前成像中获得的数据以及透视与超声心动图等不同成像模式的实时融合结合起来,投射并注册在患者身体上。需要克服的持续技术挑战包括将不同的成像模式集成到 VR/AR 中以及协调数据流和接口。持续性技术挑战包括将不同的成像模式集成到 VR/AR 中以及协调数据流和接口。网络晕动症可能会使一些患者和用户无法从 VR/AR 的潜在益处中受益。在脆弱患者中应用 VR/AR 会引发一些关键的伦理问题。此外,数字应用程序不能分散医生对患者的注意力。作为医生,我们有责任参与这些创新的开发,以确保在现实世界环境中为患者带来虚拟健康的益处。本文旨在总结 VR 和 AR 在心脏病学不同领域中的当前和未来作用、挑战和展望。
JACC Cardiovasc Imaging. 2022-3
Biomed Eng Online. 2023-7-31
J Med Internet Res. 2023-3-10
J Biomed Inform. 2020-11
Curr Probl Cardiol. 2024-3
Eur Heart J Digit Health. 2025-4-29
Health Care Sci. 2025-6-1
Eur Heart J Digit Health. 2025-3-25
Herzschrittmacherther Elektrophysiol. 2025-5-12
J Soc Cardiovasc Angiogr Interv. 2024-12-10
J Soc Cardiovasc Angiogr Interv. 2025-3-18
Healthcare (Basel). 2025-4-1
Bioengineering (Basel). 2025-3-13